Atossa Therapeutics Statistics
NASDAQ: ATOSHealthcareBiotechnologyUSD
2.42-0.04 (-1.63%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Atossa Therapeutics by the numbers
Atossa Therapeutics has a market capitalization of $24.1 million based on 9.98M shares outstanding. With trailing EPS of $-4.45, Atossa Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.2% above its 50-day average and 46.5% below its 200-day average.
Average daily trading volume is 63.48K shares, or about $153,617 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ATOS valuation vs. peer median
| Metric | ATOS | Peer median | Difference |
|---|---|---|---|
| Market cap | $24.15M | $25.60M | -6% |
| Avg. volume | 63.48K | 370.88K | -83% |
Peer median across 8 companies: KYNB, ATYR, BYSI, ABVC, MCRB, QNRX, CNTX, EVAX.
Valuation
- Market cap
- $24.15M
- EPS (TTM)
- $-4.45
- Shares outstanding
- 9.98M
Price and trading
- Previous close
- 2.46
- Open
- 2.46
- Day range
- 2.39 – 2.48
- 52-week range
- 1.70 – 18.00
- 52-week change
- -85.47%
- Beta
- —
- Volume
- 100.78K
- Average volume
- 63.48K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 24.15M
- Forward Pe
- -0.73
- Eps
- -4.45
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 18.00
- Week52 Low
- 1.70
- Avg Volume
- 63,478.00
- Shares Outstanding
- 9.98M
- Ma50
- 2.39
- Ma200
- 4.52
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -86.56%
- Pct From52w Low
- 42.35%